ARCHIVES

Letters: Alternatives Needs Scrutiny, Investigator Open-Mindedness

This article is from The Cancer Letter archive.

Vol. 19 No. 47 | December 3, 1993

Download PDF Visit The Full Archive

Related Articles

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

In Brief: ESMO Names Annual Award Winners

October 10, 2014

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

November 29, 2002

Senate Approves 15% Increase For NIH; House Passes 5.6% Raise, But Favors More.

July 7, 2000

NCI Publishes Report On Pancreatic Cancer

March 7, 2014

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005